Company profile
Corbin Therapeutics company profile
Corbin Therapeutics is a provider of a drug discovery platform. The company's biotechnology platform develops drugs from ubiquitin carboxyl-terminal hydrolase 15 (USP15) enzyme to treat various inflammation-based diseases.
Business identity
- Website
- http://corbinthera.com/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Maple Bay, British Columbia, Canada
- Postal code
- H4X 1Z5
- Country code
- CA
- Continent
- North America